Nilsri, N.; Mekchaaum, R.; Kalasin, S.; Jongjitwimol, J.; Daowtak, K.
CRISPR/Cas9-Based Modeling of JAK2 V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents. Int. J. Mol. Sci. 2025, 26, 4600.
https://doi.org/10.3390/ijms26104600
AMA Style
Nilsri N, Mekchaaum R, Kalasin S, Jongjitwimol J, Daowtak K.
CRISPR/Cas9-Based Modeling of JAK2 V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents. International Journal of Molecular Sciences. 2025; 26(10):4600.
https://doi.org/10.3390/ijms26104600
Chicago/Turabian Style
Nilsri, Nungruthai, Rujira Mekchaaum, Supaporn Kalasin, Jirapas Jongjitwimol, and Krai Daowtak.
2025. "CRISPR/Cas9-Based Modeling of JAK2 V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents" International Journal of Molecular Sciences 26, no. 10: 4600.
https://doi.org/10.3390/ijms26104600
APA Style
Nilsri, N., Mekchaaum, R., Kalasin, S., Jongjitwimol, J., & Daowtak, K.
(2025). CRISPR/Cas9-Based Modeling of JAK2 V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents. International Journal of Molecular Sciences, 26(10), 4600.
https://doi.org/10.3390/ijms26104600